US 12403090
Oral film compositions and dosage forms having precise active dissolution profiles
granted A61KA61K31/551A61K31/5513
Quick answer
US patent 12403090 (Oral film compositions and dosage forms having precise active dissolution profiles) held by Aquestive Therapeutics, Inc. expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aquestive Therapeutics, Inc.
- Grant date
- Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/551, A61K31/5513, A61K9/0056, A61K9/006